Suryawanshi, Gajendra W.
Arokium, Hubert
Kim, Sanggu
Khamaikawin, Wannisa
Lin, Samantha
Shimizu, Saki
Chupradit, Koollawat
Lee, YooJin
Xie, Yiming
Guan, Xin
Suryawanshi, Vasantika
Presson, Angela P.
An, Dong-Sung
Chen, Irvin S. Y. http://orcid.org/0000-0003-1199-2415
Funding for this research was provided by:
national institutes of health (5U19AI117941, AI110297, AI145038, HL125030, HL126544)
california institute for regenerative medicine (DR1-01431, TRX-01431-1)
Article History
Received: 21 July 2021
Accepted: 27 August 2021
First Online: 7 October 2021
Declarations
:
: The UCLA Institutional Review Board (IRB) has determined that fetal tissues from diseased fetuses obtained without patient identification information are not human subjects and its use is exempt from IRB approval. Written informed consent was obtained from patients for use of these tissues for research purposes. All mice were maintained at the UCLA Center for AIDS Research (CFAR) Humanized Mouse Core Laboratory in accordance with a protocol approved by the UCLA Animal Research Committee.
: Not applicable.
: Dr. Irvin S.Y. Chen has a financial interest in CSL Behring and Calimmune Inc. No funding was provided by these companies to support this work; Dr. Dong Sung An has a financial interest in Calimmune Inc and CSL Behring that the University of California Regents have licensed intellectual property invented by Dong Sung An, that is being used in the research, to Calimmune Inc. No funding was provided by these companies to support this work. All other authors declare no competing interests.